Back to School: How biopharma can reboot drug development. Access exclusive analysis here
THLD will restructure and reduce headcount by 12 (27%) to 32 across all departments. The company will focus on
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury